Doctors and health experts are sounding the alarm about a rare but serious heart condition called transthyretin amyloid cardiomyopathy, or ATTR-CM. This condition happens when proteins in the body misfold and build up in the heart. These deposits make the heart walls stiff and thick, which makes it very hard for the heart to pump blood. While anyone can develop this disease, it is often overlooked or misdiagnosed as regular heart failure or just a sign of getting older. Many people live with the condition for years without knowing the real cause of their fatigue and breathing problems.

The impact of ATTR-CM is felt most deeply in Black and Afro-Caribbean communities. Research shows that about 3% to 4% of Black Americans carry a specific gene change called the V122I mutation. This mutation significantly increases the risk of developing the hereditary form of the disease. Despite this high risk, many people in these communities face a long and difficult path to a correct diagnosis. Dr. Richard Allen Williams, founder of the Association of Black Cardiologists, recently noted that people in Black communities often face delays in care and a lack of awareness about their risks.

The symptoms of ATTR-CM can be tricky because they often seem like other health issues. Patients might feel short of breath during simple tasks like walking up the stairs or feel unusually tired all the time. Other signs include swelling in the legs, an irregular heartbeat, or even numbness and pain in the wrists known as carpal tunnel syndrome. Because these symptoms are so common, nearly half of patients are first diagnosed with a different heart problem. This confusion can lead to years of unnecessary suffering before the true cause is found and treated.

Getting an early diagnosis is vital because ATTR-CM is a progressive disease that gets worse over time. Recent medical studies from early 2026 show that new treatments can help stabilize the heart and reduce the number of times a person has to go to the hospital. Doctors now use non-invasive tests like special heart scans and simple blood work to check for the protein buildup. These tools make it much easier to catch the disease early without needing a painful heart biopsy.

Advocates like Howard “H” White are now sharing their stories to help others recognize the signs before it is too late. He found out his heart was failing after years of being told his symptoms were just from his past as an athlete. His experience highlights why it is so important for patients to speak up and ask their doctors specific questions. If you have heart failure but still feel like something is not right, you should specifically ask your healthcare provider about ATTR-CM and the available testing options.

Understanding your family health history is one of the best ways to protect yourself and your loved ones. Since the hereditary form of the disease is passed down through families, knowing if a relative had heart failure can provide a major clue for your doctor. You can visit the Ask About ATTR-CM website to find more information and resources. Taking the time to learn about these risks and talking openly with a medical professional can help ensure that more people receive the life-saving care they deserve.